• During an initial incubation, HEV antibody in the sample binds with HEV antigen coated onto wells of a polystyrene stripped plate. (cdc.gov)
  • This recommendation is consistent with testing practices for hepatitis B surface antigen and antibody to human immunodeficiency virus (HIV), for which laboratories routinely conduct more specific reflex testing before reporting a result as positive ( 1 , 3 ). (cdc.gov)
  • Presence of hepatitis B surface antigen (HbsAg) and alanine-aminotransferase (ALAT) level are routinely assessed, as well as HIV and human T-lymphotropic virus type l infection. (cdc.gov)
  • Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. (jci.org)
  • It has been postulated that host immune defects are responsible for the development and persistence of the hepatitis B surface antigen (HBsAg) carrier state. (jci.org)
  • The synthesis of both anti-HBs and antibody to hepatitis B core antigen (anti-HBc) in cultures containing peripheral blood mononuclear cells from chronic HBsAg carriers and from control (antibody-positive) patients was measured in the presence of pokeweed mitogen. (jci.org)
  • Multiple epitopes of hepatitis B virus surface antigen targeted by human plasma-derived immunoglobulins coincide with clinically observed escape mutations. (nih.gov)
  • To detect the presence of IgG, IgM antibodies and Hepatitis B surface antigen against these microorganisms were carried out using a chemiluminescence immunoassay analyzer (CLIA). (hindawi.com)
  • A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients. (druglib.com)
  • BACKGROUND: The safety of the immune complexes composed of yeast-derived hepatitis B surface antigen (HBsAg) and antibodies (abbreviated as YIC) among healthy adults and chronic hepatitis B patients has been proved in phase I and phase IIa trial. (druglib.com)
  • The invention relates to recombinant chimeric rabbit/human monoclonal antibody fragments (Fabs) against hepatitis B Virus e-antigen (HBeAg), notably Fab me6. (nih.gov)
  • Hepatitis B core antigen (HBcAg) forms an icosahedral structure containing the viral genome. (nih.gov)
  • Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. (nih.gov)
  • BACKGROUND: Testing for antibody to hepatitis B core antigen (anti-HBc) as a surrogate for hepatitis C viremia is no longer needed for blood donor screening. (nih.gov)
  • Currently, the important question is how much its use supplements hepatitis B surface antigen (HBsAg) donor screening in preventing transfusion-transmitted hepatitis B virus (HBV) infection. (nih.gov)
  • Qualitative detection of IgG antibodies to Hepatitis B Core Antigen in human serum or plasma. (blallab.com)
  • Anti-soluble liver antigen/liver pancreas (anti-SLA/LP) antibodies. (medlineplus.gov)
  • Assay is a chemiluminescent immunoassay for the qualitative detection of total antibody to hepatitis B core antigen in human serum and plasma specimens. (bloodworksnw.org)
  • Assay is qualitative enzyme-linked immunosorbent assay for the detection of total antibody to hepatitis B virus core antigen in human serum or plasma. (bloodworksnw.org)
  • An antigen is a substance that induces antibody production. (hepatitisprohelp.com)
  • Hepatitis B surface antigen is a protein on the surface of hepatitis B virus. (hepatitisprohelp.com)
  • HBcAg is an antigen found in the core layer which covers the hepatitis B viral DNA. (hepatitisprohelp.com)
  • Description: The nucleocapsid of hepatitis B virus is covered by an envelope of HBV surface antigen (HBsAg), which has the common, group-specific determinant a. (essentialbiosafety.info)
  • The Protein Expression Laboratory, again in close collaboration with the Laboratory of Structural Biology Research, has closely examined, primarily by electron microscopy, the interaction of core-antigen with not only numerous monoclonal antibodies widely employed in clinical diagnosis but also the entire antibody repertoire in a patient. (nih.gov)
  • Assessment of differences in the conformational flexibility of hepatitis B virus core-antigen and e-antigen by hydrogen deuterium exchange-mass spectrometry. (nih.gov)
  • 5. That a Hepatitis B surface antigen test not be performed if the person requesting the test indicates that the test is for a prenatal assessment. (ontario.ca)
  • Hepatitis C virus (HCV) accounts for 70% of chronic hepatitis and 30% of end-stage liver disease (ESLD) in the United States. (medscape.com)
  • HCV infection causes chronic hepatitis in 85% of patients. (medscape.com)
  • Chronic hepatitis patients can transmit the virus for years without any symptoms. (hindawi.com)
  • METHODS AND PRINCIPAL FINDINGS: Two hundred forty two HBeAg-positive chronic hepatitis B patients were immunized with six injections of either 30 microg YIC, 60 microg of YIC or alum adjuvant as placebo at four-week intervals under code. (druglib.com)
  • By increasing the number of patients and injections, the therapeutic efficacy of YIC in chronic hepatitis B patients will be further evaluated. (druglib.com)
  • Order this assay only when patient has an acute or chronic hepatitis B infection. (garcialab.com)
  • Failure of appearance implies disease activity and probable chronicity but patients with HBeAb may have chronic hepatitis. (walkinlab.com)
  • Often, people with chronic hepatitis will be closely monitored to see if they develop cirrhosis or liver cancer. (hepatitisprohelp.com)
  • Chronic hepatitis can lead to complications such as cirrhosis (scarring of the liver), liver failure, and liver cancer . (nih.gov)
  • Early diagnosis and treatment of chronic hepatitis may prevent these complications. (nih.gov)
  • If your chronic hepatitis leads to liver failure or liver cancer, you may need a liver transplant . (nih.gov)
  • Normalization of serum aminotransferases and disappearance of anti-HCV antibodies do not indicate clearance of the infection. (medscape.com)
  • In a study of a cohort of Irish women infected with HCV via contaminated anti-D immunoglobulin in 1977, 47.1% of 68 women who had spontaneous clearance of HCV still had anti-HCV antibodies 18 years after the initial infection. (medscape.com)
  • Recommendations have also been developed for the prevention and control of hepatitis C virus (HCV) infection. (cdc.gov)
  • Infection with hepatitis E virus (HEV) has been responsible for large water-borne epidemics of acute disease in developing countries and for acute sporadic disease in industrialized developed countries. (cdc.gov)
  • NHANES testing for markers of infection with hepatitis viruses will be used to determine secular trends in infection rates across most age and racial/ethnic groups, and will provide a national picture of the epidemiologic determinants of these infections. (cdc.gov)
  • Testing for the presence of antibody to hepatitis C virus (anti-HCV) is recommended for initially identifying persons with hepatitis C virus (HCV) infection (CDC. (cdc.gov)
  • Recommendations for prevention and control of hepatitis C virus [HCV] infection and HCV-related chronic disease. (cdc.gov)
  • Hepatitis C virus [‎HCV]‎ infection is widespread in Egypt. (who.int)
  • We assessed the prevalence of hepatitis C virus [‎HCV]‎ infection and associated risk factors for all 298 haemodialysis patients in 7 dialysis units in Guilan province. (who.int)
  • No co-infection with HCV and hepatitis B virus was found. (cdc.gov)
  • While that study did not identify HCV infection in 73 controls, 2 of 73 case-patients (2.7%) had HCV antibodies ( 6 ). (cdc.gov)
  • Please note that guidelines for the current diagnostic workup and management of hepatitis C (HCV) infection continue to evolve rapidly. (medscape.com)
  • Positive HCV-antibody test with negative HCV RNA by polymerase chain reaction (PCR): Inform patients they do not have evidence of current (active) HCV infection. (medscape.com)
  • Before the introduction of screening of blood donors for hepatitis C virus (HCV), the risk of acquiring HCV infection as a result of transfusion was about 10% [1]. (who.int)
  • HCV infection is the leading cause of post-transfusion hepatitis worldwide [3]. (who.int)
  • It also confirms the presence of infection in patients with inconclusive antibody reactivity. (who.int)
  • Hepatitis B is a viral infection that attacks the liver. (hepatitisfoundation.org)
  • The body typically generates protective antibodies after either natural HBV infection or through hepatitis B vaccination. (hepatitisfoundation.org)
  • Maintaining hepatitis B antibodies through natural or medical means is key to preventing liver infection. (hepatitisfoundation.org)
  • The hepatitis Be antibody blood test is a differential diagnosis, staging, and prognosis of hepatitis B infection. (walkinlab.com)
  • The presence of adequate hepatitis B surface antibodies in the blood indicates protection against hepatitis B virus infection. (hepatitisprohelp.com)
  • Hepatitis B test is performed to detect, classify, and treat hepatitis B virus infection. (hepatitisprohelp.com)
  • Anti-HBc is the first detectable antibody after HBV infection. (hepatitisprohelp.com)
  • Your body can make this antibody if you have been vaccinated, or if you have recovered from a hepatitis B infection. (hepatitisprohelp.com)
  • This will provide long-term protection against future hepatitis B infection. (hepatitisprohelp.com)
  • Although hepatitis C is not generally considered to be a sexually transmissible infection in Australia, you may wish to consider safe sex practices if blood is going to be present, or if your partner has HIV infection. (hepatitisprohelp.com)
  • Rates of infection have been relatively stable in recent years, but deaths from hepatitis C have reduced, thought to be because treatment options have become better. (hepatitisprohelp.com)
  • The positive result indicates hepatitis A infection. (redcliffelabs.com)
  • IgM antibodies are developed just after the infection and go away in a few months, while IgG antibodies are produced afterward and remain in the body for a long duration. (redcliffelabs.com)
  • Hence, this test can detect exposure or your level of immunity to hepatitis A infection. (redcliffelabs.com)
  • Also, consult a clinician to constantly check your health parameters linked with Hepatitis A infection. (redcliffelabs.com)
  • Hepatitis A is a contagious liver infection caused by the hepatitis A virus. (redcliffelabs.com)
  • Hepatitis can be an acute (short-term) infection or a chronic (long-term) infection. (nih.gov)
  • Both hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV) infection are underdiagnosed, particularly in low-income countries and in difficult-to-access populations. (nature.com)
  • Hepatitis C virus (HCV) infection is a major health problem worldwide. (nature.com)
  • Since people with hepatitis C can live for decades without symptoms, many baby boomers are unknowingly living with an infection they got many years ago that can lead to liver disease, liver failure and cancer. (ny.gov)
  • People whose hepatitis C infection resolves will have antibodies to hepatitis C virus, but will not be actively infected with the virus. (ny.gov)
  • The nature of these defects is unknown, but the absence of a readily detectable antibody response to HBsAg (anti-HBs) may be important. (jci.org)
  • Sera from 61 donors at donation and 29 follow-up visits were available for present-day assays for HBsAg, HBV DNA, anti-HBc, and antibody to HBsAg (anti-HBs). (nih.gov)
  • CONCLUSION: Some 33 to 50 percent of cases of hepatitis B that could be transmitted by transfusion of blood from HBsAg-negative donors are prevented by anti-HBc screening. (nih.gov)
  • This could account for the few cases of B and B-like posttransfusion hepatitis which are known to still occur despite careful HBsAg screening of blood donors. (pasteur.fr)
  • Hepatitis B surface antibodies are produced by the bodys immune system in response to HBsAg. (hepatitisprohelp.com)
  • Anti-HBs are antibodies produced by the bodys immune system to fight HBsAg. (hepatitisprohelp.com)
  • HBs16-31 was recognized by five HBsAg-specific T-cell lines from vaccinees with both high and low antibody titers, whereas HBs81-99 was recognized by two T-cell lines derived from vaccinees with high antibody titers. (elsevierpure.com)
  • The antibody titer against HBsAg was correlated significantly with the proliferation of vaccinee's PBLs in response to HBs81-99 (r = 0.47) but not to HBs16-31, suggesting that HBs81-99 plays a critical role in anti-HBs antibody production in humans vaccinated with HBsAg. (elsevierpure.com)
  • HCV-RNA can be found in the serum of acutely infected patients within days of exposure and may be present for months prior to the development of anti-HCV antibodies. (medscape.com)
  • DS-EIA-ANTI-HEV-G is an enzyme immunoassay kit intended for the detection of IgG antibodies to hepatitis E virus in human serum or plasma. (cdc.gov)
  • Serum specimens were processed, stored, and shipped to the Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. (cdc.gov)
  • HCV-specific antibodies were detected in 376 (67.3%) serum samples using third-generation enzyme immunoassay and confirmatory immunoblot assays. (who.int)
  • In order to provide epidemiological and clinical information on surrogate testing of blood donations, the respective prevalences of serum hepatitis B virus (HBV) markers and elevated transaminase levels were studied in 1,100 blood donors according to their geographic origin and socioeconomic level. (pasteur.fr)
  • The Hepatitis Core Igm Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. (genpcr.com)
  • Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse hepatitis B virus surface antibody (HBsAb) in samples from serum, plasma, tissue homogenates and other biological fluids. (essentialbiosafety.info)
  • Human IgG antibody Laboratories manufactures the hepatitis b virus surface antibody reagents distributed by Genprice. (essentialbiosafety.info)
  • Human IgG antibody Laboratories manufactures the hep c antibody viral rna reagents distributed by Genprice. (oegterm.at)
  • We applied cutting edge multi-omics approaches to extensively characterize temporal molecular responses following vaccination with hepatitis B virus (HBV) vaccine. (nih.gov)
  • Havrix ( hepatitis a vaccine, inactivated) is a vaccine used to help prevent the Hepatitis A disease in adults. (rxlist.com)
  • Our Havrix (hepatitis a vaccine) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. (rxlist.com)
  • HAVRIX ( Hepatitis A Vaccine) is a sterile suspension of inactivated virus for intramuscular administration. (rxlist.com)
  • According to the Centers for Disease Control and Prevention (CDC), more than 75% of adults infected with hepatitis C are people born from 1945 through 1965 (baby boomers). (ny.gov)
  • ABSTRACT The seroprevalence of hepatitis C virus (HCV) specific antibodies and HCV genotypes distribution were studied among 559 Iraqi children with thalassaemia in receipt of repeated blood transfusions. (who.int)
  • So the aims of this study were to identify the seroprevalence of hepatitis C virus specific antibodies among children with thalassaemia in receipt of blood transfusions in a teaching hospital in Baghdad and to investigate the HCV genotype distribution among these patients. (who.int)
  • Our study was aimed at screening the seroprevalence of TORCH antibodies among prepregnancy and reproductive-age women in Tabriz, Iran. (hindawi.com)
  • Stored sera from the 13 hepatitis patients and their 123 donors were tested for anti-hepatitis C virus (HCV) by ELISA and if positive, analyzed by recombinant immunoblot assay (RIBA). (lu.se)
  • Having adequate levels of antibodies confers immunity and protection against hepatitis B. If your antibody levels are low, there are some natural ways to help raise them without needing vaccination again. (hepatitisfoundation.org)
  • The gut microbiome regulates immunity, and imbalances can reduce responses to hepatitis B vaccination. (hepatitisfoundation.org)
  • Adopting a holistic approach through lifestyle, nutrition, stress relief, and gut health optimization provides a way to support hepatitis B immunity naturally. (hepatitisfoundation.org)
  • Hepatitis A Virus HAV IGG IGM Antibodies Test in Motihari is done to confirm the long-term immunity and effectiveness of the vaccination. (redcliffelabs.com)
  • Clinicians are advised to refer frequently to HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C , the most recent recommendations of the American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (ISDA). (medscape.com)
  • You may need this test if you have signs of certain liver diseases, such as hepatitis and cirrhosis . (medlineplus.gov)
  • Hepatitis B virus (HBV) is a major cause of liver disease in humans, afflicting almost 400 million worldwide, and is the leading cause of hepatic cancer. (nih.gov)
  • A. Hepatitis A is not a chronic liver disorder but can lead to debilitating signs. (redcliffelabs.com)
  • It can also cause fulminant hepatitis or acute liver failure that can prove fatal. (redcliffelabs.com)
  • Hepatitis is inflammation of the liver . (nih.gov)
  • Additional measures can be taken to protect the liver from further harm such as getting vaccinated for hepatitis A and B, decreasing or eliminating alcohol consumption and understanding the interactions among herbal supplements, over the counter medications, and prescription medications. (ny.gov)
  • Borrelia-Burgdorferi Laboratories manufactures the hepatitis core igm antibody reagents distributed by Genprice. (genpcr.com)
  • For anti-HCV antibody determination, we used a third-generation enzyme immunoassay kit (EIA-3) (UBI HCV EIA, United Biomedical, USA) at the baseline evaluation. (who.int)
  • The former was utilized for detection of anti-HCV antibodies while the latter was used for HCV-RNA detection and subsequent genotyping/subtyping. (who.int)
  • Due to the probability of vertical transmission to the fetus during pregnancy and the unpleasant complication of these pathogens, it is essential to be screened for detection of specific IgG and IgM antibodies in reproductive ages. (hindawi.com)
  • When used for early detection in patients without symptoms of hepatitis C, screening is recommended at least once for all adults aged 18 years or older, except in locations with very low prevalence of HCV. (hepatitisprohelp.com)
  • A. The hepatitis A immunoglobin IgG IgM antibody test contains testing of two vital antibody detection: IgG and IgM. (redcliffelabs.com)
  • Hepatitis viruses constitute a major public health problem because of the morbidity and mortality associated with the acute and chronic consequences of these infections. (cdc.gov)
  • In addition, NHANES provides the means to better define the epidemiology of other hepatitis viruses. (cdc.gov)
  • however, such transfusions increase their exposure only to not HCV but also to other blood-borne viruses (hepatitis B, hepatitis G, human immunodeficiency virus, transfusion transmitted virus) [2]. (who.int)
  • The successful candidate will join a research program that studies the mechanisms of antibody-mediated neutralization of hepatitis viruses and developing assay protocols to monitor virus-neutralizing activities of immunoglobulin intravenous (IGIV) products. (nih.gov)
  • This test is used to confirm whether or not an individual has been immunized for the hepatitis A & B viruses, & determine if an individual has had hepatitis C. (fantesti.co)
  • Dr. Watts' research is focused on two viruses that have great impacts on people's health, human immunodeficiency virus (HIV-1) and hepatitis B virus (HBV). (nih.gov)
  • It is caused by one of several viruses -- hepatitis viruses A , B , C , D, and E. In the United States, A, B, and C are the most common. (nih.gov)
  • Some people with hepatitis do not have symptoms and do not know they are infected. (nih.gov)
  • In addition, we have generated synthetic antibody fragments targeted against Rev that strongly inhibit HIV replication in peripheral blood mononuclear cells. (nih.gov)
  • Testing for anti-HCV should include use of an antibody screening assay, and for screening test-positive results, a more specific supplemental assay. (cdc.gov)
  • Reinfection after previous spontaneous or treatment-related viral clearance: Obtain initial HCV-RNA testing (because an HCV-antibody test is expected to be positive). (medscape.com)
  • A rapid antibody test for HCV is available. (medscape.com)
  • Anti-smooth muscle antibody is a blood test that detects the presence of antibodies against smooth muscle. (medlineplus.gov)
  • This test detects total antibodies (IgG and IgM) to the hepatitis Delta agent. (garcialab.com)
  • If this test is positive, then your immune system has successfully developed a protective antibody against the hepatitis B virus. (hepatitisprohelp.com)
  • At-home hepatitis B testing requires that users carefully follow instructions provided in the test kit to collect a small sample of blood, package the sample, and mail it to a lab for testing. (hepatitisprohelp.com)
  • The cost of hepatitis B testing depends on the tests that are performed, where the test is conducted, and a patientâs health insurance coverage. (hepatitisprohelp.com)
  • A blood test that measures the total hepatitis B core antibodies. (nh.gov)
  • The hepatitis-b-virus-total-antibodies-hbeab screening test can detect life-threatening conditions like hepatits in an individual. (redcliffelabs.com)
  • Q. What do you mean by Hepatitis A virus IgG IgM antibody test? (redcliffelabs.com)
  • Hepatitis A virus HAV IgG IgM Antibodies Test cost in Motihari is quite reasonable from Redcliffe Labs. (redcliffelabs.com)
  • A hepatitis C screening test must be offered to every individual born between 1945 and 1965 receiving health services as an inpatient or a hospital, or receiving primary care services in the outpatient department of hospital, or in a freestanding diagnostic and treatment center or from a physician, physician assistant, or nurse practitioner providing primary care. (ny.gov)
  • If an individual accepts the offer of the hepatitis C screening test and the screening test is reactive, the health care provider must offer the individual follow-up health care or refer the individual to a health care provider who can provide follow-up health care. (ny.gov)
  • The follow-up health care must include a hepatitis C diagnostic test. (ny.gov)
  • What is the difference between a hepatitis C screening test and a hepatitis C diagnostic test? (ny.gov)
  • The initial hepatitis C screening test is a test that detects the presence of hepatitis C antibodies in the blood. (ny.gov)
  • A reactive result on a hepatitis C screening test is interpreted as a presumptive positive for hepatitis C antibodies in the blood. (ny.gov)
  • EIA) and point of care (i.e., rapid test) hepatitis C antibody screening tests. (ny.gov)
  • The hepatitis C diagnostic test (also known as an HCV RNA test) is a laboratory test that detects the presence of the hepatitis C virus in the blood. (ny.gov)
  • Anti-HCV antibodies are usually measurable by enzyme-linked immunosorbent assay (ELISA) after the onset of symptoms. (medscape.com)
  • Hepatitis C in recipients occurred both after transfusion of blood that was strongly positive, weakly positive, and/or negative for anti-HCV by ELISA. (lu.se)
  • Description: This is purified Mouse monoclonal antibody against Hepatitis C virus core for WB, ELISA. (genpcr.com)
  • We report an assessment of the proportion of blood donors from the Hôpital Principal de Dakar who had HCV antibodies in 2001. (cdc.gov)
  • The prevalence of HCV antibodies in blood donors in Dakar in 2001 appears to be one of the lowest in West Africa, close to published estimates for Mauritania and Benin (1.1% and 1.4%, respectively) and lower than in other West African countries such as Ghana or Guinea, where prevalence ranges from 2.8% to 6.7% ( 1 - 4 ). (cdc.gov)
  • A systematic screening of HCV antibodies in blood donors could prevent, on average, 120 bloodborne HCV infections each year. (cdc.gov)
  • A prospective study of posttransfusion non-A, non-B hepatitis was conducted in Malmo, Sweden, in 1984-1985, in which donors were alanine aminotransferase (ALT) screened but not ALT selected. (lu.se)
  • Doctors order antibody tests to check for autoantibodies- antibodies that attack your healthy tissues and cells by mistake-such as antinuclear antibody (ANA) and anti-smooth muscle antibody (SMA). (nih.gov)
  • Treatment for hepatitis depends on which type you have and whether it is acute or chronic. (nih.gov)
  • If a patient who has hepatitis C is cured, when do the hepatitis C antibodies disappear from his blood? (medscape.com)
  • Of the 5 recipients of the RIBA-positive blood units, 3 went into hepatitis, 1 remained normal at 10.5 weeks, and 1 showed a slight, transient ALT elevation at week 12. (lu.se)
  • Testing for hepatitis B is performed on a sample of blood. (hepatitisprohelp.com)
  • Hepatitis B, hepatitis C, and hepatitis D spread through contact with the blood of someone who has the disease. (nih.gov)
  • Blood samples were tested for HCV antibodies. (nih.gov)
  • Hepatitis C is primarily spread through contact with blood from an infected person. (ny.gov)
  • We investigated hepatitis E virus (HEV) infections in Finnish veterinarians engaged in different practice specialties and evaluated the effect of different background factors on HEV exposure by examining total HEV antibodies in samples collected from the participants of the 2009 National Veterinary Congress in Helsinki, Finland. (nih.gov)
  • The tracing of the IgM antibody against TORCH pathogens is the best aspect of the recognition of these infections [ 10 ]. (hindawi.com)
  • There is no specific treatment for acute hepatitis B infections. (hepatitisprohelp.com)
  • Some types of hepatitis cause only acute infections. (nih.gov)
  • Chronic forms of hepatitis B may be treated with antiviral medications such as interferon, entecavir, tenofovir, lamivudine, and adefovir. (hepatitisprohelp.com)
  • Hepatitis C is treated with antiviral medications that aim to clear the virus from your body. (hepatitisprohelp.com)
  • Tests to detect antibody to hepatitis C virus (anti-HCV) were first licensed by the Food and Drug Administration (FDA) in 1990 ( 1 ). (cdc.gov)